Publications: Mr Thomas Moseley
Arokiasamy S, Balderstone MJM, Shaik F, Cristante E, Moseley TC, Madoo A, Rizzi M, Bainbridge JW et al.
(
2024
)
.
QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular ageārelated macular degeneration
.
British Journal of Pharmacology